The Ensign Group, Inc. (ENSG) - What Are Analysts Thinking About This Stock?

Key Points

• Analysts are broadly positive: Seven brokerages give The Ensign Group a “Moderate Buy” consensus, with five buys and two holds. The average 12-month price target is $218.60, above the reported $186.32 share price.
• Operating performance exceeded expectations: Third-quarter EPS was $2.03 versus the $1.97 consensus, while revenue increased 14.5% year over year to $1.48 billion, though it fell short of estimates. The company also raised its 2026 earnings guidance.
• Litigation remains a key risk: A securities lawsuit alleges misleading disclosures related to patient care, staffing, quality data, billing and licensing. The claims remain unproven but could create legal, regulatory and reputational pressure.

The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report) has received an average rating of "Moderate Buy" from the seven brokerages that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $218.60.

Several brokerages recently issued reports on ENSG. Truist Financial set a $210.00 target price on The Ensign Group and gave the company a "hold" rating in a research note on Thursday. Oppenheimer boosted their price objective on The Ensign Group from $210.00 to $215.00 and gave the stock an "outperform" rating in a research note on Thursday. Royal Bank Of Canada reissued an "outperform" rating and issued a $228.00 target price on shares of The Ensign Group in a research note on Tuesday, July 28th. Weiss Ratings upgraded shares of The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Finally, UBS Group reaffirmed a "buy" rating and set a $240.00 price target (up from $230.00) on shares of The Ensign Group in a research note on Thursday.

Key Headlines Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Q3 earnings beat expectations: Ensign reported third-quarter EPS of $2.03, exceeding the $1.97 consensus estimate, while revenue rose 14.5% year over year to approximately $1.48 billion. Revenue was below analyst expectations, but the earnings outperformance and continued growth supported investor sentiment. Ensign Group Q3 2026 Earnings Call Transcript
• Positive Sentiment: 2026 outlook raised: The company increased its earnings guidance for 2026, reinforcing expectations for continued operating and earnings growth. UBS analyst A.J. Rice maintained a Buy rating, citing strong operating trends and the improved outlook. Ensign Raises 2026 Earnings Guidance
• Positive Sentiment: Higher analyst price target: Oppenheimer raised its target from $210 to $215 and reiterated an “outperform” rating, implying meaningful upside from the recent trading level.
• Neutral Sentiment: Multiple law firms publicized the same securities lawsuit: Firms including Rosen, Faruqi & Faruqi, Pomerantz and others reminded investors of a December 7, 2026 deadline to seek lead-plaintiff status for a class action covering purchases from February 10, 2022, through June 18, 2026. The announcements largely repeat existing information rather than represent new legal developments. Rosen Ensign Securities Lawsuit Notice
• Negative Sentiment: Litigation remains an overhang: The lawsuit alleges misleading disclosures involving patient care, staffing and quality data, billing practices and an administrator-license arrangement. The allegations have not been proven, but potential legal costs, regulatory scrutiny and reputational damage could pressure ENSG if the claims advance. BFA Law Ensign Lawsuit Notice

Institutional Trading of The Ensign Group

Large investors have recently made changes to their positions in the stock. Transamerica Financial Advisors LLC purchased a new stake in The Ensign Group in the 2nd quarter valued at about $26,000. Caitlin John LLC bought a new position in The Ensign Group in the 2nd quarter worth about $31,000. Cedar Mountain Advisors LLC purchased a new position in shares of The Ensign Group during the first quarter worth approximately $32,000. Northwestern Mutual Wealth Management Co. purchased a new position in shares of The Ensign Group during the second quarter worth approximately $33,000. Finally, Continuum Advisory LLC purchased a new position in shares of The Ensign Group during the second quarter worth approximately $34,000. 96.12% of the stock is owned by hedge funds and other institutional investors.

The Ensign Group Trading Up 1.2%

Shares of ENSG stock opened at $186.32 on Friday. The company has a current ratio of 1.20, a quick ratio of 1.21 and a debt-to-equity ratio of 0.08. The Ensign Group has a 12-month low of $141.58 and a 12-month high of $218.00. The stock has a market capitalization of $10.87 billion, a P/E ratio of 27.73, a P/E/G ratio of 1.74 and a beta of 0.66. The firm's 50 day moving average is $174.76 and its 200 day moving average is $181.56.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $2.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.97 by $0.06. The Ensign Group had a return on equity of 16.79% and a net margin of 7.03%. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same period in the previous year, the company posted $1.64 EPS. The business's quarterly revenue was up 14.5% compared to the same quarter last year. Research analysts expect that The Ensign Group will post 7.04 earnings per share for the current year.

The Ensign Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, October 31st. Shareholders of record on Wednesday, September 30th will be given a $0.0650 dividend. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend is Wednesday, September 30th. The Ensign Group's dividend payout ratio is 4.08%.

The Ensign Group Company Profile

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.